TrialInternational journal of molecular sciences2013

Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.

Masato Ohsawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.